x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:05:36

Celebrating the 2025 Nucleate Alumni Summit

BiotechTV - News ·

2025/08/19

Nucleate leaders describe what Nucleate has done for their education and career, and what they are looking forward to at this year's global summit in Boston.

en-us

00:06:13

After exiting stealth with $20 million two weeks ago,...

BiotechTV - News ·

2025/08/19

Founder & CEO Ashoka Rejendra describes what the company offers, which is a not only a software package, but guidance on how to build and plan for the future. New entrepreneurs like those attending the Nucleate Summit are a natural prospect.

en-us

00:33:07

Biotech Direct: MassBio CEO Kendalle Burlin O'Connell...

BiotechTV - News ·

2025/08/15

In this inaugural episode of Biotech Direct, BiotechTV's new show that will share the biotech industry's perspective on policy and regulatory news, Kendalle Burlin O'Connell and Daphne Zohar discuss the strategic importance of biotech to the United States, share their thoughts on new FDA initiatives, and brainstorm ways to raise public awareness of the importance of science.

en-us

00:20:54

IO Biotech CEO Mai-Britt Zocca discusses the phase 3...

BiotechTV - News ·

2025/08/15

Dr. Zocca describes the results of the trial, which showed a 19.4 months vs. 11.0 months mPFS benefit versus pembro alone, but narrowly missed statistical significance. She shares her take on the totality of the data and discusses the road ahead, including a Q3 meeting the company will have with FDA.

en-us

00:24:21

Checking in on the progress of CAR-T for autoimmune...

BiotechTV - News ·

2025/08/13

Warner Biddle describes the trajectory of the field, and how neuro-autoimmune conditions have emerged as Kyverna's most advanced programs. We discuss Stiff Person Syndrome, myasthenia gravis, MS and more.

en-us

00:08:06

Bay Area based Nosis Bio is leveraging AI to get its...

BiotechTV - News ·

2025/08/13

Co-Founder & CEO Jim Martineau walks us through the platform and describes the importance of being cell type specific. The company utilized a combination of AI and high-throughput chemistry in the wet lab.

en-us

00:19:41

Checking in with Alector CEO Arnon Rosenthal ahead of...

BiotechTV - News ·

2025/08/13

Dr. Rosenthal describes the unmet need in frontotemporal dementia and mechanism of action of latozinemab. He covers the trial design and explains why a new co-primary endpoint was recently added to the statistical plan. Plus, developing a similar medicine for early stage Alzheimer's, and how Alector is trying to get therapies across the blood-brain barrier more efficiently.

en-us

00:18:01

IDEAYA Biosciences is at the forefront of precision...

BiotechTV - News ·

2025/08/12

Founder & CEO Yujiro Hata describes the idea behind precision medicine and synthetic lethality. We discuss the company's pipeline assets Darovasertib, a DLL3 ADC, MAT2A, and more.

en-us

00:18:47

CytomX Therapeutics' years of work on its 'Probody'...

BiotechTV - News ·

2025/08/12

Chairman & CEO Sean McCarthy walks us through the science and describes what CytomX has learned about it over many years of working on masking. He discusses the recent EpCAM data, and highlights IFN-α2b and partnered programs.

en-us

00:14:21

Maze Therapeutics, which had its IPO earlier this...

BiotechTV - News ·

2025/08/12

CEO Jason Coloma walks us through the science that is taking place at the company's South San Francisco headquarters, and descrbies the development programs. The lead program for APOL1-Mediated Kidney Disease is in phase 2, and a second for PKU and Chronic Kidney Disease will have important healthy volunteer proof of concept data this quarter.

en-us

00:12:51

Astria Therapeutics licensed its HAE treatment,...

BiotechTV - News ·

2025/08/07

President and CEO Jill Milne describes what she believes is the unmet need and profile of Navenibart, and walks us through future anticipated developments. Plus, discussing the company's OX40 antagonist for atopic dermatitis that will have key healthy volunteer proof of concept data in the third quarter of this year.

en-us

00:18:33

AI News: While most AI in healthcare is aimed at...

BiotechTV - News ·

2025/08/07

Founder & CEO Steve Brown, who created CureWise after receiving his own diagnosis of a rare blood cancer, describes his journey and how CureWise is meant to help patients. Its goal is to start with a diversity of opinions from multiple sources and help them converge on a diagnosis.

en-us

00:19:27

From Indianapolis: Serial entrepreneur Derek Small...

BiotechTV - News ·

2025/08/05

He discusses the idea behind Syndeio, which focuses on synaptic function and has a lead program in major depressive disorder. Plus, other work he is doing, and Derek's take on the growth and maturity of the biotech ecosystem in Indiana.

en-us

00:06:11

From Indianapolis: Adipo Therapeutics is approaching...

BiotechTV - News ·

2025/08/05

CEO Karen Wurster describes the science behind the company, which recently presented proof-of-concept data from human cells at the ADA meeting. Plus, what it is like working from the IBRI in Indianapolis and being an Indiana biotech company.

en-us

00:09:11

The Indiana Biosciences Research Institute is a...

BiotechTV - News ·

2025/08/05

IBRI CEO Alan Palkowitz descrbies the work that takes place at the IBRI, which includes both the institute's own research and how it acts as an incubator to biotech companies. Plus, the state of biotech in Indiana and what its strengths are here.

en-us

00:10:38

BiotechTV visits Indiana University School of...

BiotechTV - News ·

2025/08/04

Dr. Lamb, a noted expert in neuroscience and Alzheimer's research, introduces us to Stark and describes the investment in people and equipment that has been made here. The institute has two key focuses of 1) modeling Alzheimer's disease and 2) how to expedite research understandings to treat it. Plus, he discusses a company he has co-founded, called Monument Biosciences, that is focusing on the neuroinflamatory side of the disease.

en-us

00:25:48

Former NIH Director and Co-Founder of ModeX...

BiotechTV - News ·

2025/07/30

He highlights his new memoir, Disease Knows No Politics, and gives his opinion on what is at stake in preserving NIH and other scientific funding. Plus, how ModeX is working on multispecifics for cancer and autoimmune conditions, and multivalent vaccines.

en-us

00:09:41

AI x Bio Summit: Proscia CEO David West describes how...

BiotechTV - News ·

2025/07/25

He describes how computing power in pathology is augmenting the work that pathologists traditionally do, but also is becoming an increasing important tool in precision medicine.

en-us

00:18:31

Monte Rosa Therapeutics' CEO Markus Warmuth updates...

BiotechTV - News ·

2025/07/24

The company, which recently had a paper earn a spot on the cover of Science, is progressing ahead with both I&I and oncology indications. Dr. Warmuth walks us through the pipeline progress and overall strategy of finding and pursuing targets.

en-us

00:26:55

Abivax CEO Marc de Garidel discusses Obefazimod's...

BiotechTV - News ·

2025/07/24

He covers the mechanism of action, this week's efficacy and safety data, what it might mean for the maintenance trial that will read out in 2Q26, additional indications, IP, business development, and more.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter